UKIM-1 was also associated with an increased risk of CKD progression when comparing the highest to the lowest quartile (aHR 3.03; 95% CI, 1.92 to 4,76), and it seemed to have a similar effect with urinary epidermal growth factor (uEGF). Here, EGF is linked to chronic kidney disease.